Why Pharmaceutical Companies Aren’t In A Rush To Address Increasing Antibiotic Resistance – Forbes


Forbes
Why Pharmaceutical Companies Aren’t In A Rush To Address Increasing Antibiotic Resistance
Forbes
Is the pharmaceutical industry doing enough to combat antimicrobial resistance? “Enough for whom?”, is one critical question, and “how?” is another. If we mean that pharma companies should combat resistance by promoting antibiotic stewardship and thus …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd